CUSIP 603170101COMMLYSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
222 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Catalys Pacific, LLC | 7.90M | $286.83M | −1.00M | Reduced |
| 2 | Ra Capital Management, L.P. | 7.32M | $265.78M | 0 | Held |
| 3 | Samsara Biocapital, LLC | 5.87M | $213.06M | −392.1K | Reduced |
| 4 | Fmr LLC | 5.06M | $183.54M |
| +2.99M |
| Added |
| 5 | Blackrock, Inc. | 4.33M | $157.05M | +656.1K | Added |
| 6 | Vanguard Group Inc | 3.35M | $121.68M | +333.9K | Added |
| 7 | State Street Corp | 3.18M | $115.58M | +1.88M | Added |
| 8 | Caligan Partners LP | 2.77M | $100.62M | 0 | Held |
| 9 | Franklin Resources Inc | 1.79M | $64.91M | −21.0K | Reduced |
| 10 | Laurion Capital Management LP | 1.71M | $62.18M | −7.0K | Reduced |
See every fund holding Mineralys Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders